Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.422 USD | -0.41% | -18.72% | +58.48% |
Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
Apr. 11 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | 2.03M | Sales 2025 * | - | Capitalization | 23.6M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | - | EV / Sales 2024 * | 11.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.98
x | P/E ratio 2025 * |
-
| Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
1 day | -7.50% | ||
1 week | -16.54% | ||
Current month | -14.62% | ||
1 month | +9.90% | ||
3 months | +15.32% | ||
6 months | +79.03% | ||
Current year | +59.14% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Patel
CEO | Chief Executive Officer | 67 | 96-12-31 |
Anthony DelConte
CTO | Chief Tech/Sci/R&D Officer | 66 | - |
Krista Fogarty
AUD | Comptroller/Controller/Auditor | 56 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Dana Ono
BRD | Director/Board Member | 71 | 14-01-05 |
Mahesh Patel
CEO | Chief Executive Officer | 67 | 96-12-31 |
John W. Higuchi
BRD | Director/Board Member | 56 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.422 | -0.41% | 772 |
24-04-24 | 4.44 | -7.50% | 66,373 |
24-04-23 | 4.8 | -5.33% | 76,675 |
24-04-22 | 5.07 | -3.80% | 21,546 |
24-04-19 | 5.27 | -3.13% | 11,286 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.14% | 23.6M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.51% | 22.2B | |
-16.53% | 21.23B | |
-10.12% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- LPCN Stock